Precision Medicine Group Acquires Project Farma
January 14, 2021
Precision Medicine Group has acquired Project Farma, a bioengineering services firm specializing in biomanufacturing strategy and facility implementation with a focus on cell and gene therapies. The deal brings Project Farma's manufacturing and scale-up expertise into Precision's cell and gene therapy services (Precision ADVANCE) to expand end-to-end development, manufacturing, and commercialization capabilities.
- Buyers
- Precision Medicine Group
- Targets
- Project Farma
- Industry
- Healthcare Services
- Location
- Connecticut, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.